Exhibit 10.1
CERTAIN INFORMATION CONTAINED IN THIS EXHIBIT, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE REGISTRANT HAS DETERMINED THE INFORMATION IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
FIRST AMENDMENT TO CREDIT AGREEMENT
This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”)
is made and entered into as of July 1, 2026 by and among ARS PHARMACEUTICALS OPERATIONS, INC., a Delaware corporation (the “Borrower”), ARS PHARMACEUTICALS, INC., a Delaware corporation (“Parent”), as a Guarantor, the Lenders party hereto and RA CAPITAL AGENCY SERVICES, LLC, as administrative agent for the Lenders (together with its Affiliates, successors, transferees and assignees, the “Administrative Agent”).
WHEREAS, the Borrower, Parent, the Lenders and the Administrative Agent entered into a Credit Agreement, dated as of September 29, 2025 (the “Credit Agreement”), pursuant to which the Lenders have extended credit to the Borrower on the terms set forth therein;
WHEREAS, pursuant to Section 12.01 of the Credit Agreement, the Credit Agreement may be amended by an instrument in writing signed by the Borrower or the applicable Loan Party and the Required Lenders and acknowledged by the Administrative Agent;
WHEREAS, the undersigned Lenders comprise all Lenders (including the Required Lenders) under the Credit Agreement; and
WHEREAS, the Borrower, Parent and the Lenders desire to amend certain provisions of the Credit Agreement as provided in this Amendment.
NOW, THEREFORE, in consideration of the mutual agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
definition shall have the meanings assigned to such terms in the Credit Agreement. This Amendment shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents.
(a) Section 1.01 of the Credit Agreement is hereby amended by inserting the following new defined terms therein in the proper alphabetical order:
“First Amendment” means the First Amendment to the Agreement, dated as of the First Amendment Effective Date, among Parent, the Borrower, the Lenders party thereto and the Administrative Agent.
“First Amendment Effective Date” means July 1, 2026.
“[***] License” means the exclusive license granted to the Borrower under the Licensed Technology to Exploit the Licensed Products (as each such term is defined under the [***] License Agreement) pursuant to the [***] License Agreement.
“[***] License Agreement” means that certain License Agreement, dated as of the First Amendment Effective Date, by and between the Borrower and [***], as amended, supplemented, or otherwise modified in accordance with the terms hereof from time to time.